"Phase II study of tolerance and efficacy of hyperfractionated radiothe" by Andre Abitbol, Alan Lewin et al.

Menu

Skip to main content

All Publications

Andre Abitbol, Miami Cancer InstituteFollow
Alan Lewin, Miami Cancer InstituteFollow
Michael Troner, Miami Cancer InstituteFollow
Maria-Amelia Rodrigues, Miami Cancer InstituteFollow

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol

Publication Date

2002

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

International Journal of Radiation Oncology, Biology, Physics (2002) 53(4):942-7

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS